1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

18 Jun 2024
Admin
News Article

EPAM Acquires Odysseus to Transform the Life Sciences Value Chain with Advanced Analytics, Data Methods and AI

EPAM acquires Odysseus to transform the life sciences value chain with advanced analytics, data methods and AI

Overview

EPAM Systems, Inc., a leading digital transformation services and product engineering company, announced its acquisition of Odysseus Data Services, Inc., a top health data analytics company. Odysseus will expand EPAM’s ability to transform the life sciences value chain through advanced data analytics, data methods and artificial intelligence (AI).

Words from EPAM

“We are pleased to have Odysseus join EPAM. With their strong capabilities in Real-World Evidence and Real-World Data, the ‘glue’ between multiple segments of the life sciences value chain — our natural synergies make this an exciting time to add this to our portfolio to help our clients achieve better outcomes,” said Greg Killian, senior vice president of life sciences at EPAM.
We see the next wave of innovation based on standardized data powering AI and GenAI to improve life sciences research, clinical studies and post-market surveillance. Based on the combined strengths of EPAM and Odysseus, we are well positioned to lead that innovation.

About Odysseus

Headquartered in Cambridge, Massachusetts, Odysseus generates healthcare data insights and evidence for clients through skilled data science and analytics, software engineering and data management and ontology and vocabulary management.
The company’s focus on a standardized and systematic approach to healthcare data analytics is the foundation for a better understanding of the inner workings of healthcare interventions in drug treatment, drug safety and efficacy, epidemiological research, provider support, quality measurements and cost reduction.
Odysseus is an active member of the Observational Health Data Sciences and Informatics"" (OHDSI) collaborative and is intimately involved in the open standards and open science community through participation in research and development, including OMOP CDM, open source tools and methods.

Words from CEO: Odysseus

Gregory Klebanov, CEO, Odysseus, said “With EPAM’s strong foundation in AI, machine learning, data analytics and data management and cloud infrastructure combined with our healthcare data analytics and Real World Evidence expertise, we can address the whole life sciences value chain more comprehensively.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!